Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NVTA

Invitae (NVTA) Stock Price, News & Analysis

Invitae logo

About Invitae Stock (NYSE:NVTA)

Advanced Chart

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.02
$0.02
Volume
75 shs
Average Volume
23.72 million shs
Market Capitalization
$80,103.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Receive NVTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invitae and its competitors with MarketBeat's FREE daily newsletter.

NVTA Stock News Headlines

Elon’s 2025 Silver Crisis (What It Means for You)
Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.
Labcorp to acquire Invitae assets for $239 million
Labcorp wins $239M bid for bankrupt Invitae
See More Headlines

NVTA Stock Analysis - Frequently Asked Questions

Invitae Co. (NYSE:NVTA) released its quarterly earnings results on Tuesday, May, 9th. The medical research company reported ($0.37) EPS for the quarter, beating the consensus estimate of ($0.41) by $0.04. The business's revenue for the quarter was down 5.1% compared to the same quarter last year.

Invitae (NVTA) raised $76 million in an IPO on Thursday, February 12th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan acted as the underwriter for the IPO and Cowen and Company and Leerink Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invitae investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), CrowdStrike (CRWD), Teladoc Health (TDOC) and PayPal (PYPL).

Company Calendar

Last Earnings
5/09/2023
Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NYSE:NVTA
Fax
N/A
Employees
1,700
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.11 billion
Net Margins
-299.14%
Pretax Margin
-301.93%

Debt

Sales & Book Value

Annual Sales
$481.58 million
Price / Cash Flow
N/A
Book Value
$0.42 per share
Price / Book
0.00

Miscellaneous

Free Float
284,373,000
Market Cap
$80,103.00
Optionable
Optionable
Beta
1.59

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:NVTA) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners